Trade PMVP stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
PMV Pharmaceuticals, Inc. (PMVP) is trading at US$1.36, down 6.85% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$71.1M. Over the past 52 weeks, PMVP has traded between US$1.02 and US$1.88. On Syfe you can trade PMVP with $0 commission and add it to your watchlist.
| Previous close | US$1.46 |
|---|---|
| Market cap | US$71.1M |
| 52-week range | US$1.02 – US$1.88 |
| Volume | 705.42K |
| Exchange | US |
Add to Watchlist
Set Price Alert
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. is a precision oncology company, which engages in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in March 2013 and is headquartered in Princeton, NJ.
Year: 2020
--Oppenheimer Adjusts Price Target on PMV Pharmaceuticals to $5 From $6, Maintains Outperform Rating
May 13, 1:02 PM · MT Newswires
PMV Pharmaceuticals, Inc. (PMVP) stock is trading at US$1.36, -6.85% from the previous close of US$1.46.
The market cap for PMV Pharmaceuticals, Inc. (PMVP) stock is approximately US$71.1M.
The 52-week high for PMV Pharmaceuticals, Inc. (PMVP) stock is US$1.88.
The 52-week low for PMV Pharmaceuticals, Inc. (PMVP) stock is US$1.02.
PMV Pharmaceuticals, Inc. (PMVP) does not currently pay a dividend.
Stay on top of PMVP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
